首页> 外国专利> A Gram negative bacterium origin comprising a mutation in a Gene, an immunogenic vaccine composition, a composition, a method for producing a Mutant of this bacterium, a method for producing such a polynucleotide attenuated bacteria, Purified and isolated the same, VEC

A Gram negative bacterium origin comprising a mutation in a Gene, an immunogenic vaccine composition, a composition, a method for producing a Mutant of this bacterium, a method for producing such a polynucleotide attenuated bacteria, Purified and isolated the same, VEC

机译:包含基因突变的革兰氏阴性细菌起源,免疫原性疫苗组合物,组合物,该细菌突变体的产生方法,这种多核苷酸减毒细菌的产生方法,经纯化和分离的VEC

摘要

Origin is a Gram negative bacterium that has a mutation in a Gene represented by a sequence of nucleotides that do not appear in any of the. SEC.(Identification of Sequence Numbers): 1, 3, 7, 9, 21, 25, 27, 29, 39, 41, 51, 53, 55, 57, 58, 60, 68, 72, 74, 76, 78, 80, 82, 84, 104, 108, 112, 116, 118, 120, 122, 124, 126, 128 and 130, or their homologous species, producing such a mutation decreased activity in a Gene Product codif Qualified by the Gene mutated; also includes a mutation in a Gene, an immunogenic composition,A vaccine composition, a method for producing such a Mutant bacterium, a method for producing such a polynucleotide attenuated bacteria, Purified and isolated the same, a Vector, a host Cell, a method for producing a recombinant polypeptide, an Antibody, a method Using the monoclonal antibody and a method for identifying an antibacterial agent.Identify virulence genes of Gram negative bacteria, which allows the identification of New antibacterial agents that target these virulence genes and their products, and obtain New mutants useful in Gram negative bacterial Vaccines.
机译:起源是革兰氏阴性细菌,它在一个基因中具有一个突变,该突变由一个序列中未出现的任何核苷酸表示。 SEC。(序列号识别):1、3、7、9、21、25、27、29、39、41、51、53、55、57、58、60、68、72、74、76、78 ,80、82、84、104、108、112、116、118、120、122、124、126、128和130或它们的同源物种,产生这样的突变会降低经突变基因鉴定的基因产物codif中的活性;还包括基因突变,免疫原性组合物,疫苗组合物,产生这种突变细菌的方法,产生这种多核苷酸减毒细菌的方法,纯化和分离的方法,载体,宿主细胞,方法产生重组多肽的方法,抗体,使用单克隆抗体的方法以及鉴定抗菌剂的方法。鉴定革兰氏阴性细菌的毒力基因,从而可以鉴定靶向这些毒力基因及其产物的新型抗菌剂,以及获得可用于革兰氏阴性细菌疫苗的新突变体。

著录项

  • 公开/公告号AR029622A1

    专利类型

  • 公开/公告日2003-07-10

    原文格式PDF

  • 申请/专利权人 PHARMACIA & UPJOHN COMPANY;

    申请/专利号AR2000P101619

  • 发明设计人

    申请日2000-04-07

  • 分类号C12N1/21;C12N15/63;C12N15/31;C07K14/285;C12N16/12;A61K35/74;A61K39/02;C12Q1/18;

  • 国家 AR

  • 入库时间 2022-08-22 00:04:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号